Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Treat hair loss with medicine, continue indefinitely.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

EH-MSCs may help treat hair loss by reducing inflammation.

Mesotherapy might help with hair growth in androgenic alopecia, but more research is needed.

Lower vitamin D levels are linked to more severe hair loss in men.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

PRP therapy improves hair growth safely in androgenetic alopecia but needs standardized methods.

Ayurvedic treatment improved PCOS symptoms and hormone levels.

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.

Oral minoxidil boosts hair growth and reduces shedding in androgenetic alopecia.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Combining PRP therapy with minoxidil is the most effective treatment for hair loss in men.

PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.